StoxApollo Hospitals Enterprise vs Dr. Reddy's Laboratories: share price & financials comparison
NSE: APOLLOHOSP vs DRREDDY · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Apollo Hospitals Enterprise vs Dr. Reddy's Laboratories at a glance
Apollo Hospitals Enterprise (APOLLOHOSP) has a market capitalisation of ₹1,21,453 Cr, against ₹1,14,646 Cr for Dr. Reddy's Laboratories (DRREDDY). Over the past year Dr. Reddy's Laboratories has returned +9.8%, compared with +7.5% for Apollo Hospitals Enterprise. On valuation, Dr. Reddy's Laboratories trades at a lower P/E of 40.9 versus 54.2. Apollo Hospitals Enterprise earns a higher return on equity (21.1% vs 7.2%). Apollo Hospitals Enterprise comes out ahead on profitability and growth. Dr. Reddy's Laboratories comes out ahead on size, valuation, financial health and technicals. Across the scored metrics below, Apollo Hospitals Enterprise leads on 8 and Dr. Reddy's Laboratories on 10. On StoxGud's 10-point checklist, Apollo Hospitals Enterprise scores 8/10 and Dr. Reddy's Laboratories scores 5/10.
| Metric | Apollo Hospitals Enterprise | Dr. Reddy's Laboratories |
|---|---|---|
| Size | ||
| Market cap | ₹1,21,453 Cr | ₹1,14,646 Cr |
| Revenue (latest FY) | ₹25,228 Cr | ₹33,700 Cr |
| Net profit (latest FY) | ₹1,942 Cr | ₹4,196 Cr |
| Valuation | ||
| P/E | 54.2 | 40.9 |
| P/B | 11.45 | 2.95 |
| Dividend yield | 0.24% | 0.58% |
| Profitability | ||
| Return on equity | 21.1% | 7.2% |
| Net profit margin | 8.1% | 8.5% |
| Operating margin | 15.4% | 14.7% |
| Growth | ||
| Revenue growth (YoY) | +20.8% | -1.5% |
| Net profit growth (YoY) | +32.0% | -31.3% |
| Revenue CAGR (multi-year) | +19.0% | +12.1% |
| Financial health | ||
| Debt to equity | 0.53 | 0.15 |
| Momentum | ||
| 1-month return | +6.7% | +14.1% |
| 1-year return | +7.5% | +9.8% |
| 3-year CAGR | +17.8% | +8.7% |
| 5-year CAGR | +13.9% | +7.5% |
| 10-year CAGR | +20.8% | +8.3% |
| Distance from 52W high | -6.9% | -0.2% |
| Technicals | ||
| RSI (14) | 66 | 84 |
| Price vs 200-day avg | +3.9% | +9.9% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Apollo Hospitals Enterprise | Dr. Reddy's Laboratories |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 8/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Apollo Hospitals Enterprise or Dr. Reddy's Laboratories?
Apollo Hospitals Enterprise has a market cap of ₹1,21,453 Cr and Dr. Reddy's Laboratories has a market cap of ₹1,14,646 Cr as of 06 Nov 2026.
Which has a lower P/E, Apollo Hospitals Enterprise or Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories has the lower P/E: Apollo Hospitals Enterprise trades at 54.2 and Dr. Reddy's Laboratories at 40.9.
Which gave better returns in the last year, Apollo Hospitals Enterprise or Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories did better: Apollo Hospitals Enterprise returned +7.5% and Dr. Reddy's Laboratories returned +9.8% over one year.
Is Apollo Hospitals Enterprise or Dr. Reddy's Laboratories a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Apollo Hospitals Enterprise scores 8/10 and Dr. Reddy's Laboratories scores 5/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.